Talking Points on Deprescribing in Hospice Care

Talking Points on Deprescribing in Hospice Care

Shrivastava, Deepak

Taylor & Francis Ltd

04/2024

169

Dura

Inglês

9781032491080

15 a 20 dias

Descrição não disponível.
Introduction
Physiologic changes of terminal illness
Fundamentals of deprescribing
Deprescribing Statins
Deprescribing Benzodiazepines
Deprescribing Antipsychotics
Deprescribing SSRI and SNRIs
Deprescribing Tricyclic Antidepressants
Deprescribing Anticholinergic drugs for parkinsonism
Deprescribing Anticholinergic drugs for urinary incontinence
Deprescribing muscle relaxants
Deprescribing long-term Opioids
Deprescribing Proton Pump Inhibitors
Deprescribing Allopurinol
Deprescribing Antihyperglycemics Oral
Deprescribing Antihyperglycemics Injectable
Deprescribing anti-hypertensives
Deprescribing Anticoagulants
Deprescribing Cholinesterase inhibitors
Deprescribing Glaucoma eye drops
Deprescribing Vitamin D and Calcium
Deprescribing NSAIDs
Deprescribing gabapentin and pregabalin
Deprescribing long-acting Beta agonist
Deprescribing Vitamins
Deprescribing medications in children
Deprescribing in Transgender and LGBTQ
Cultural competency in deprescribing
Chaplain and medical social worker
When to restart discontinued medications.
Medicolegal aspects of deprescribing
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
medication side effects;drug interactions;polypharmacy and hospice;nonessential medications;pill burden;quality of life